Literature DB >> 24390362

Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI.

Kalie Y Kebed1, Raed I Al Adham, Kalkidan Bishu, J Wells Askew, Kyle W Klarich, Jae K Oh, Paul R Julsrud, Thomas A Foley, James F Glockner, Rick A Nishimura, Steve R Ommen, Nandan S Anavekar.   

Abstract

The presence of apical pouches in hypertrophic cardiomyopathy (HCM) may portend poor prognosis. We sought to study if the use cardiac magnetic resonance imaging (CMR) improves the detection of apical pouches in HCM compared to echocardiography. A retrospective review was performed of all consecutive HCM patients with an apical pouch identified by CMR at Mayo Clinic from May 2004 to Sept 2011. Clinical data was abstracted and CMR and echocardiographic images were analyzed. There were 56 consecutive HCM patients with an apical pouch identified by CMR. The predominant morphological type was apical in 41 (73.2 %), followed by sigmoid in 6 (10.7 %), reversed curve in 6 (10.7 %) and neutral in 3 (5.4 %). Obstructive physiology or systolic anterior motion of the mitral valve leaflet was evident in 23 (41.1 %). Late gadolinium enhancement was present in 47 (87.0 %) patients. Apical pouches were detected in only 18 (32.1 %) patients on echocardiography. Even when intravenous contrast was used (29/56 patients), in 16/29 (55.2 %) pouches were missed on echocardiography. Pouch length and neck dimensions in systole and diastole, measured on CMR, were larger among those patients in whom pouches were detected on echocardiography suggesting only larger pouches can be identified on echocardiography. In the largest CMR series to date of apical pouches in HCM, we show that while apical pouches are most commonly seen in apical HCM, they can be found in other phenotypic variants. CMR is better suited for the evaluation of apical pouches compared to echocardiography even with the use of intravenous contrast. CMR is likely a better tool for evaluating the cardiac apical structures including apical pouches when clinically indicated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390362     DOI: 10.1007/s10554-013-0355-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  20 in total

1.  Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching.

Authors:  Josepha Binder; Christine H Attenhofer Jost; Kyle W Klarich; Heidi M Connolly; A Jamil Tajik; Christopher G Scott; Paul R Julsrud; Jo-Ellen Ehrsam; Kent R Bailey; Steve R Ommen
Journal:  J Am Soc Echocardiogr       Date:  2011-04-20       Impact factor: 5.251

2.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

3.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

4.  Apical segmental dysfunction in hypertrophic cardiomyopathy: subgroup with unique clinical features.

Authors:  H Ando; T Imaizumi; Y Urabe; A Takeshita; M Nakamura
Journal:  J Am Coll Cardiol       Date:  1990-12       Impact factor: 24.094

5.  Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy.

Authors:  Rossella Fattori; Elena Biagini; Massimiliano Lorenzini; Katia Buttazzi; Luigi Lovato; Claudio Rapezzi
Journal:  Am J Cardiol       Date:  2010-04-10       Impact factor: 2.778

6.  Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations.

Authors:  Josepha Binder; Steve R Ommen; Bernard J Gersh; Sara L Van Driest; A Jamil Tajik; Rick A Nishimura; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2006-04       Impact factor: 7.616

7.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.

Authors:  H G Klues; A Schiffers; B J Maron
Journal:  J Am Coll Cardiol       Date:  1995-12       Impact factor: 24.094

8.  Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.

Authors:  W McKenna; J Deanfield; A Faruqui; D England; C Oakley; J Goodwin
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

9.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

10.  Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy.

Authors:  Kyung-Hee Kim; Hyung-Kwan Kim; In-Chang Hwang; Seung-Pyo Lee; Eun-Ah Park; Whal Lee; Yong-Jin Kim; Jae-Hyung Park; Dae-Won Sohn
Journal:  J Cardiovasc Magn Reson       Date:  2012-07-28       Impact factor: 5.364

View more
  1 in total

Review 1.  Cardiovascular imaging 2014 in the International Journal of Cardiovascular Imaging.

Authors: 
Journal:  Int J Cardiovasc Imaging       Date:  2015-03       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.